Lountzis Asset Management, LLC Laboratory Corp Of America Holdings Transaction History

Lountzis Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$197.69 - $227.29 $3,558 - $4,091	-18 Reduced 0.19%	9,518 $2.16 Million
Q2 2023 Aug 15, 2023	SELL	$211.93 - $241.33 $55,101 - $62,745	-260 Reduced 2.65%	9,536 $2.09 Million
Q4 2022 Feb 07, 2023	SELL	$203.72 - $248.97 $47,874 - $58,507	-235 Reduced 2.34%	9,796 $2.4 Million
Q3 2022 Oct 25, 2022	SELL	$204.81 - $262.19 $52,840 - $67,645	-258 Reduced 2.51%	10,031 $2.05 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $1,069 - $1,389	-5 Reduced 0.05%	10,289 $2.41 Million
Q4 2021 Jan 26, 2022	SELL	$271.6 - $314.21 $4,888 - $5,655	-18 Reduced 0.17%	10,294 $3.23 Million
Q3 2020 Nov 05, 2020	SELL	$167.03 - $201.3 $1,670 - $2,013	-10 Reduced 0.1%	10,312 $1.94 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $1.17 Million - $1.88 Million	10,322 New	10,322 $1.72 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Lountzis Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Lountzis Asset Management, LLC with notifications on news.